Skip to main content

Global Navigation

  • Other sites:
  • ECDC
  • European Antibiotic Awareness Day
  • ESCAIDE - Scientific conference
  • Eurosurveillance journal
European Centre for Disease Prevention and Control

European Centre for Disease Prevention and Control

An agency of the European Union

Main Navigation

  • Home
  • All topics: A to Z

Secondary Navigation

  • News & events
  • Publications & data
  • Tools
  • About us
  • Search

Search

  1. Home
  2. Homepage
Filter by
  • Filter by
  • Remove this filter Infectious disease: Human papillomavirus infection
  • Remove this filter Country: Europe
  • Infectious disease
    • Human papillomavirus infection (9)
    • Vaccine preventable diseases (9)
    • Cutaneous warts (9)
    • Sexually transmitted infections (2)
    • Food- and waterborne diseases (1)
    • Pertussis (1)
    • Tetanus (1)
    • Diphtheria (1)
    • Respiratory diseases (1)
    • Varicella (1)
    • Tick-borne diseases (1)
    • Poliomyelitis (1)
    • Rubella (1)
    • Measles (1)
    • Viral hepatitis (1)
    • Hepatitis B (1)
    • Hepatitis A (1)
    • Tuberculosis (1)
    • Haemophilus influenzae type b (HiB) infection (1)
    • Rotavirus infection (1)
    • Influenza (1)
    • Invasive Haemophilus influenzae disease (1)
    • Meningococcal disease (1)
    • Pneumococcal disease (1)
    • Whooping cough (1)
    • German measles (1)
    • Chickenpox (1)
    • Haemophilus infection (1)
    • Influenza in humans, seasonal (1)
    • Invasive meningococcal disease (1)
    • Invasive pneumococcal disease (1)
    • Streptococcus pneumoniae (1)
    • S. pneumoniae (1)
    • Seasonal influenza (1)
    • Flu (1)
  • Public health area
    • Immunisation (9)
    • Vaccination (9)
    • Active immunisation (9)
    • Prevention and control (3)
    • Scientific advice (3)
    • Disease prevention (3)
    • Prophylaxis (3)
    • Determinant (1)
    • Vaccine hesitancy (1)
  • Country
    • Europe (9)
      • EU/EEA (6)
      • European Union Member State/European Economic Area (3)
      • Denmark (1)
      • Italy (1)
      • Norway (1)
      • Slovenia (1)
      • Sweden (1)
  • Type
    • Publication (4)
    • News (4)
    • ECDC comment (3)
    • Peer-reviewed publication (1)
    • Technical report (1)
    • Public consultation (1)
    • Technical guidance (1)
    • Expert opinion (1)
    • Press release (1)
    • Data (1)
    • Tool (1)
  • Page 1 of 1 // 9 Results found
    • Sort by:

Publication

Technical guidance on the Introduction of HPV vaccines in European Union countries – an update

Technical guidance - 5 Sep 2012

In January 2008, a panel of ECDC experts produced the Guidance for the introduction of HPV vaccines in EU countries. Since then, the European Union has come a long way: most countries have implemented national vaccination programmes for adolescent girls and a significant number have also introduced catch-up programmes for young women.

20120905_GUI_HPV_vaccine_update.pdf - EN - [PDF-990.92 KB]
  • EU/EEA
  • Europe
  • Human papillomavirus infection
  • Immunisation
  • Scientific advice
  • Sexually transmitted infections

Publication

Expert opinion on the Introduction of HPV Vaccines in EU Countries

Expert opinion - 22 Jan 2008

This guidance report lays down the scientific basis for the potential introduction of human papillomavirus (HPV) vaccines in order to help EU Member States to make policy choices

0801_GUI_Introduction_of_HPV_Vaccines_in_EU.pdf - EN - [PDF-526.45 KB]
  • Europe
  • Human papillomavirus infection
  • Immunisation
  • Scientific advice

News

Estimated acceptance of HPV vaccination among Italian women aged 18–26 yearsArchived

ECDC comment - 24 Oct 2011

The low immunisation rate reported highlights the difficulties of reaching young adult women.

  • Human papillomavirus infection
  • Immunisation
  • Italy

News

Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: A cervical cancer screening based studyArchived

ECDC comment - 23 Nov 2011

Similar to other European countries, cervical infection with HPV-16, the HPV type with the strongest oncogenic potential, were most common both overall and among women with cervical disease.

  • Human papillomavirus infection
  • Immunisation
  • Slovenia

News

Introduction of human papillomavirus vaccination in Nordic countriesArchived

ECDC comment - 16 Dec 2011

The paper provides and interesting review of the introduction of HPV vaccines in the Nordic countries.

  • Denmark
  • Human papillomavirus infection
  • Immunisation
  • Norway
  • Sweden

Data

ECDC Vaccine Scheduler

Tool - 1 Jan 2013

The Vaccine Scheduler is an interactive tool that shows vaccination schedules for individual EU/EEA countries and specific age groups. With this tool comparisons can be made for vaccination schedules between two countries or by disease for all or a selection of countries.

  • Diphtheria
  • Europe
  • Hepatitis A
  • Hepatitis B
  • Human papillomavirus infection
  • Immunisation
  • Influenza in humans, seasonal
  • Invasive Haemophilus influenzae disease
  • Measles
  • Meningococcal disease
  • Pertussis
  • Pneumococcal disease
  • Poliomyelitis
  • Prevention and control
  • Rotavirus infection
  • Rubella
  • Tetanus
  • Tick-borne diseases
  • Tuberculosis
  • Varicella

News

ECDC guidance on HPV vaccination: Focus on reaching all girlsArchived

Press release - 4 Sep 2012

Today, ECDC publishes an update to its 2008 Guidance on human papillomavirus (HPV) vaccines in Europe. The update follows the introduction of vaccination programmes in 19 European countries and new evidence from research studies over the past four years.

  • EU/EEA
  • Human papillomavirus infection
  • Immunisation
  • Prevention and control

Publication

Public consultation on HPV vaccines guidance opens

Public consultation - 1 Apr 2019

This guidance covers the following areas in relation to HPV vaccination: efficacy of the nine-valent HPV vaccine, HPV vaccination in people living with HIV and HPV vaccination in males and the cost-effectiveness of extending the HPV vaccination programme to include males.

Public consultation on draft guidance for introduction of HPV vaccines in EU countries: focus on 9-valent HPV vaccine and vaccination of boys and people living with HIV - EN - [PDF-1.69 MB]
  • EU/EEA
  • Human papillomavirus infection
  • Immunisation
  • Scientific advice
  • Vaccine preventable diseases

Peer-Reviewed Publication

HPV vaccination in a context of public mistrust and uncertainty: a systematic literature review of determinants of HPV vaccine hesitancy in Europe

Feb 2019 - Hum Vaccin Immunother - 15(7-8):1615-1627

Karafillakis, E., Simas, C., Jarrett, C., Verger, P., Peretti-Watel, P., Dib, F., De Angelis, S., Takacs, J., Ali, K.A., Pastore Celentano, L., Larson, H.

  • Determinant
  • Europe
  • Human papillomavirus infection
  • Immunisation
  • Prevention and control
  • Vaccine hesitancy
  • About us

    • What we do
    • Who we are
    • Governance
    • Partnerships and networks
  • Work with us

    • Vacancies
    • Fellowships
    • Traineeships
    • Procurement and grants
  • Contact ECDC

    • Visit us
    • ECDC press room
    • Social media
Log in to ECDC Extranet
Newsletter RSS

Follow us:

Facebook Twitter Youtube Linked In Vimeo Slide share

Footer Navigation

  • Legal notice
  • Copyright
  • Access to TESSy data
  • Personal data protection
  • Language policy
  • Cookie policy
  • Accessibility
  • Sitemap
© European Centre for Disease Prevention and Control (ECDC) 2019
  • Other sites:
    • ECDC
    • European Antibiotic Awareness Day
    • ESCAIDE - Scientific conference
    • Eurosurveillance journal
  • Home
  • All topics: A to Z
  • News & events
  • Publications & data
  • Tools
  • About us